igf 1 lr3 fda approval status IGF-1 (1 MG) IGF-1 LR3 1mg Research Vial

Description

Gut 60 (10), 13091316

doi: 10.1038/onc.2010.215

however, these drugs have been misused Currently available data do not suggest that rhGH treatment should be used to promote longevity Lack of GH action in mouse models is associated with extended longevity, but the mechanism underlying the increased lifespan has yet to be established Given the effects of reduced GH/IGF-1 signalling on lifespan in rodents, decreased GH action might be beneficial for humans, but clinical trials are needed to assess long-term outcome of GH/IGF-1 inhibition This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

High-resolution PTP1B inhibition profiling combined with high-performance liquid chromatographyhigh-resolution mass spectrometrysolid-phase extractionnuclear magnetic resonance spectroscopy: proof-of-concept and antidiabetic constituents in crude extract of Eremophila lucida